Abstract:Summary Type 2 diabetes mellitus (T2D) was a metabolic disorder,which was characterized by hyperglycemia in the context of insulin resistance and relative lack of insulin.The prevalence of T2D resulted in 90% of diabetic individuals suffering from it.In China,the percentage increased by 95%.The usage of anti-diabetic drug,however, could be associated with serious undesirable side effects,the most commonly observed are being hypoglycemia, mass gain,and gastrointestinal disturbances.Thus,it was necessary to find anti-diabetic therapies that are not only safe and effective in controlling blood glucose levels,but also without serious side effects.Tea was a kind of natural anti-diabetic material and had been studied for a long time because it was abundant in polyphenol.Previous studies mainly focused on type 1 diabetes mellitus (T1D),but recently,research about anti-T2D increased.At present, three main approaches of remedies could be concluded from the global researches. Glucose concentration in the body was directly influenced by insulin,so that insulin approach was one of the main therapies to treat T2D.Numerous reports showed that tea extracts could enhance insulin properties which could be subdivided into the amelioration of insulin resistance,improvement of insulin sensitivity and stimulation of incretin in cell or animal models.In detail,studies showed that tea extracts,especially epigallocatechin gallate(EGCG)could inhibit protein tyrosine phosphates 1 b (PTP1 B) to enhance insulin sensitivity and relieve insulin resistance via inhibiting 1 1 beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1).Similar results were also found that unknown extracts from tea could alleviate insulin resistance or enhance insulin secretion by inhibiting dipeptidyl peptidase Ⅳ(DPP-Ⅳ). This kind of approach includes two remedies,enhancing glycolysis and inhibiting gluconeogenesis.In skeletal muscle and adipose cells,tea extracts,particularly EGCG,could analog the function of insulin to stimulate glucose transporter protein-4 (GLUT 4) and enhance AMP-activated protein kinase (AMPK) pathway or PI3K/Akt pathway to strengthen the usage of glucose.In hepatic cells,EGCG from tea,down-regulated the mRNA of phosphoenolpyruvate carboxylase (PEPCK) and up-regulated the mRNA of glucose-6-phosphatase (G6Pase) through enhancing calmodulin dependent protein kinase kinases-β(CaMKK-β) and AMPK pathway. Anti-oxidants have been proved to play a significant role in T2D and complications.Tea,as a natural anti-oxidant,could definitely scavenge free radicals. Studies have reported that it could prevent T2D and its complications through enhancing polyol pathway flux,increasing formation of advanced glycation end products (AGEs),increasing expression of the receptor for AGEs and its activating ligands,activation of protein kinase C isoforms,and overactivity of the hexosamine pathway. Additionally,tea polyphenols including EGCG could also keep the balance between nitric oxide (NO) and endothelin(ET-1)and inhibit 11β-HSD1 to prevent T2D from happening indirectly. As a kind of natural functional beverage,tea and its extracts would be totally tested on resistance to T2D and could be recommended for combined use with present antidiabetic drugs in the treatment of T2D in the future.

Natural 8-C-ascorbyl-(−)-epigallocatechin As Antidiabetic Agent: Α-Glucosidase and PTP-1B Signaling Pathway Dual Regulators

Combined Effects of Green Tea Extracts, Green Tea Polyphenols or Epigallocatechin Gallate with Acarbose on Inhibition Against Α-Amylase and Α-Glucosidase in Vitro

Natural α-glucosidase inhibitors from Aquilaria sinensis leaf-tea: Targeted bio-affinity screening, identification, and inhibition mechanism

Advances in Molecular Mechanisms of Tea Polyphenols in Preventing Type 2 Diabetes Mellitus

A Comparative Study on Antioxidant Activity and Inhibitory Potential Against Key Enzymes Related to Type 2 Diabetes of Four Typical Teas

Synthesis, Stability, and Antidiabetic Activity Evaluation of (−)-Epigallocatechin Gallate (EGCG) Palmitate Derived from Natural Tea Polyphenols

Screening and identification of natural α-glucosidase and α-amylase inhibitors from partridge tea (Mallotus furetianus Muell-Arg) and in silico analysis

Physicochemical characterization of puerh tea polysaccharides and their antioxidant and α-glycosidase inhibition

Improving Regulation of Polymeric Proanthocyanidins and Tea Polyphenols against Postprandial Hyperglycemia <i>via</i> Acid-Catalyzed Transformation

Oral administration of puerh tea polysaccharides lowers blood glucose levels and enhances antioxidant status in alloxan-induced diabetic mice.

Anti-α-Glucosidase Activities and Bioactive Components of Tibetan Hull-Less Barley Bran Extracts

Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes

Explore the active ingredients and potential mechanism of action on Actinidia arguta leaves against T2DM by integration of serum pharmacochemistry and network pharmacology

Study on the Hypoglycemic Mechanism of Tea Polysaccharides and Tea Polyphenols

Overview of tea constituents against type 2 diabetes

Effect of Black Tea Polysaccharides on Alleviating Type 2 Diabetes Mellitus by Regulating PI3K/Akt/GLUT2 Pathway

Inhibition Mechanism of Α-Glucosidase by Three Geranylated Compounds: Kinetic, Spectroscopic and Molecular Docking

Design and synthesis of epigallocatechin (EGC) analogs selective to inhibit α-amylase over α-glucosidases via the incorporation of caffeine acid and its derivatives

Effects of Soluble Tea Polysaccharides on Hyperglycemia in Alloxan-Diabetic Mice

Comparative evaluation for phytochemical composition and regulation of blood glucose, hepatic oxidative stress and insulin resistance in mice and HepG2 models of four typical Chinese dark teas

α-Glucosidase inhibition by green, white and oolong teas: in vitro activity and computational studies